Locations:
Search IconSearch
December 5, 2017/Cancer/News & Insight

Understanding Fear and Death

Can we get it without going through it ourselves?

bolwell_650x450

In his regular column in Oncology Times, Chair of Physician Leadership and Development and former Chair of Taussig Cancer Institute Brian Bolwell, MD, FACP, explores topics critical to leading cancer centers in today’s healthcare environment. His latest column shares how his own experience with a serious illness informs his view of patients with cancer.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

I thought about dying a lot, and what life for my family would be after I died. I was not paralyzed by this; but up until then—even while taking care of so many cancer patients who did not survive—the reality and inevitability of my own death was compartmentalized someplace way back in my brain, not a part of my conscious thought or everyday life. Then after the illness, the compartment door sprang open and it became front and center. You think about your illness and mortality every day—multiple times a day. Like breathing, it is always there and happens without thought. In some ways it was liberating as I made choices on a different timeline with my own, new sense of prioritization. We splurged on family vacations. I thought about what added value more than my previous duty-bound tasks. But the issue of death, my death, was there all the time.



Over the years, I think about it less. But it is still there; persistent.



If you talk to cancer survivors, it’s there for them as well. For a very long time. Forever.



So how is this of any use for all of you who care for cancer patients? Well, first of all, it’s a good idea to think of minority rights. Majority opinion does not always lead to the correct path. Many cancer caregivers believe we should publicly celebrate the completion of a patient’s course of chemotherapy. However, a minority of patients in your cancer center are fully aware that their death is right around the corner. Their prognosis is fully defined. Nobody is more important than these patients. They and their families are following their path as best they can, even if the path is palliative. Treat them with respect, consideration, and empathy. Consider that loud celebrations when another patient completes chemotherapy might be especially painful for them. Think about the patients who can’t help but think of their mortality. So conduct more private celebrations. Walk in the shoes of those who will not be with us next year…

Read the full column here.

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad